Clinical trial
Top-down Infliximab Study in Kids With Crohn's Disease
NCT02517684 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Top-down Infliximab Study in Kids With Crohn's Disease
- Lead sponsor
- Erasmus Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2015
- Completion date
- January 31, 2024
- Enrollment
- 100 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
crohn's disease